Meeder Asset Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-189
Closed -$65.4K 868
2024
Q1
$65.4K Sell
189
-267
-59% -$92.3K ﹤0.01% 362
2023
Q4
$147K Hold
456
0.01% 357
2023
Q3
$163K Hold
456
0.01% 330
2023
Q2
$173K Hold
456
0.01% 340
2023
Q1
$218K Buy
+456
New +$218K 0.02% 295
2022
Q4
Sell
-73
Closed -$30K 924
2022
Q3
$30K Sell
73
-134
-65% -$55.1K ﹤0.01% 978
2022
Q2
$102K Sell
207
-145
-41% -$71.4K 0.01% 728
2022
Q1
$198K Sell
352
-624
-64% -$351K 0.01% 656
2021
Q4
$738K Buy
976
+48
+5% +$36.3K 0.07% 171
2021
Q3
$692K Sell
928
-21
-2% -$15.7K 0.04% 336
2021
Q2
$611K Sell
949
-234
-20% -$151K 0.03% 406
2021
Q1
$676K Buy
1,183
+1,141
+2,717% +$652K 0.03% 354
2020
Q4
$24K Sell
42
-968
-96% -$553K 0.01% 751
2020
Q3
$521K Buy
1,010
+39
+4% +$20.1K 0.03% 348
2020
Q2
$440K Buy
971
+7
+0.7% +$3.17K 0.03% 403
2020
Q1
$339K Buy
964
+355
+58% +$125K 0.03% 436
2019
Q4
$225K Buy
609
+19
+3% +$7.02K 0.01% 567
2019
Q3
$197K Buy
590
+450
+321% +$150K 0.01% 608
2019
Q2
$44K Buy
140
+3
+2% +$943 ﹤0.01% 983
2019
Q1
$42K Hold
137
﹤0.01% 911
2018
Q4
$32K Sell
137
-3,407
-96% -$796K ﹤0.01% 924
2018
Q3
$1.11M Buy
3,544
+1,647
+87% +$515K 0.08% 208
2018
Q2
$547K Buy
1,897
+1,842
+3,349% +$531K 0.05% 351
2018
Q1
$14K Sell
55
-216
-80% -$55K ﹤0.01% 974
2017
Q4
$65K Sell
271
-347
-56% -$83.2K 0.01% 635
2017
Q3
$137K Buy
618
+600
+3,333% +$133K 0.01% 519
2017
Q2
$4K Buy
+18
New +$4K ﹤0.01% 1239
2016
Q4
Sell
-648
Closed -$106K 981
2016
Q3
$106K Sell
648
-1,207
-65% -$197K 0.01% 595
2016
Q2
$266K Buy
1,855
+716
+63% +$103K 0.02% 532
2016
Q1
$156K Buy
1,139
+1,128
+10,255% +$154K 0.01% 623
2015
Q4
$2K Buy
+11
New +$2K ﹤0.01% 794
2014
Q4
Sell
-4,225
Closed -$479K 450
2014
Q3
$479K Hold
4,225
0.07% 257
2014
Q2
$506K Buy
+4,225
New +$506K 0.08% 222
2013
Q4
Sell
-25,760
Closed -$3.03M 347
2013
Q3
$3.03M Hold
25,760
0.58% 49
2013
Q2
$2.89M Buy
+25,760
New +$2.89M 0.57% 60